Clinical trial Recruiting at 1 site Phase 2 Interventional Ages 18 and up Women only

Effect of Tamsulosin on urinary retention after pelvic surgery

Official title: The Impact of Tamsulosin on Duration of Post-Operative Urinary Retention in Women Undergoing Pelvic Reconstructive Surgery- A Double Blind, Randomized, Placebo-Controlled Study

Run by Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) · NCT04597372 · Data updated 2026-11-12

This study is testing if Tamsulosin can help women who have urinary retention after pelvic surgery get better faster than those who receive a placebo.

More Urinary Retention trials

Quick facts

PhasePhase 2
Study typeInterventional
Ages18 Years and up
SexWomen only
Enrollment154 (estimated)
SponsorAllegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
Academic / other
Locations1 site (Pittsburgh, Pennsylvania)
StatusRecruiting
StartedNovember 3, 2021
Main results expectedDecember 2026
Study endsDecember 2026
Registry record updatedMarch 20, 2026
Trial IDNCT04597372 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are women aged 18 and older who experience postoperative urinary retention after pelvic reconstructive surgery.

Probably not a fit

Patients with a history of urinary retention prior to surgery or those with severe comorbid conditions may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to evaluate the effectiveness of Tamsulosin in reducing the duration of acute postoperative urinary retention (POUR) in women following pelvic reconstructive surgery. It is a double-blind, randomized, placebo-controlled trial where participants will receive either Tamsulosin or a placebo after being diagnosed with POUR. The primary outcome will be the duration of catheterization, measured in days, and secondary outcomes include the incidence of urinary tract infections and quality of life assessments using the Euroqol-5D (EQ-5D) scale. The study will involve women aged 18 and older who consent to participate and meet specific eligibility criteria.

Why it matters

Potential benefit: If successful, this study could lead to improved management of urinary retention post-surgery, enhancing recovery and quality of life for patients.

How similar studies have gone: Other studies have shown promising results with Tamsulosin in similar contexts, suggesting potential for success in this approach.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* 18 years or older
* willing and able to provide informed consent
* postoperative urinary retention as defined by a failed RGVT prior to hospital discharge
* Ability to speak and read English
* Tolerate pill ingestion

Exclusion Criteria:

* allergy/intolerance to Tamsulosin or sulfa drugs
* preoperative history of urinary retention as defined by preoperative post void residual of \>150mL
* current use of alpha antagonist medication for hypertension
* severe dementia
* end stage renal or liver disease
* history of severe heart failure or major cardiovascular event in the last 6 months

Where it's running

  • West Penn Hospital
    Pittsburgh, Pennsylvania, United States
    Recruiting

Study contacts

  • Principal investigator: Lindsay Turner, MD — Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
  • Study coordinator: Lindsay Turner
  • Email: lindsay.turner@AHN.ORG
  • Phone: (412)-330-4567

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.